Keene & Associates Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PIMCO Enhanced Short Maturity Active Exchange-Traded Fund
MINT
|
+$10.9M |
| 2 |
SLB Ltd
SLB
|
+$3.09M |
| 3 |
B
Barrick Mining
B
|
+$501K |
| 4 |
Cisco
CSCO
|
+$379K |
| 5 |
Smith & Nephew
SNN
|
+$273K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
3M
MMM
|
+$2.69M |
| 2 |
McKesson
MCK
|
+$891K |
| 3 |
Adobe
ADBE
|
+$434K |
| 4 |
Synaptics
SYNA
|
+$226K |
| 5 |
Pfizer
PFE
|
+$138K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Staples | 21.83% |
| 2 | Healthcare | 20.32% |
| 3 | Technology | 12.94% |
| 4 | Industrials | 7.77% |
| 5 | Energy | 7.32% |
Similar funds
Keene & Associates's Q3 2022 Portfolio in Review
As of Q3 2022, Keene & Associates held 83 positions worth $109M, up 1.9% from $107M the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Keene & Associates deployed $12.9M of net new capital in Q3 2022, opening 3 new positions and adding to 44 existing holdings. Its largest new stake was PIMCO Enhanced Short Maturity Active Exchange-Traded Fund: 109,895 shares worth $10.9M.
By sector, the portfolio is most concentrated in Consumer Staples at 22% of assets, down from 24% a quarter earlier, followed by Healthcare and Technology.
On the sell side, the largest reduction was McKesson, an estimated $891K trimmed.
- Keene & Associates's largest Q3 2022 buy was PIMCO Enhanced Short Maturity Active Exchange-Traded Fund: 109,895 shares worth $10.9M.
- Keene & Associates added most to SLB Ltd in Q3 2022, an estimated $3.09M increase.
- Keene & Associates's biggest Q3 2022 reduction was McKesson, cutting an estimated $891K.
- Keene & Associates fully exited 3M in Q3 2022, selling an estimated $2.69M.
- Keene & Associates's ten largest holdings make up 37% of its $109M portfolio in Q3 2022.
- Keene & Associates opened 3 new positions and closed 5 in Q3 2022.
- Keene & Associates's portfolio value rose 1.9% quarter-over-quarter to $109M.
Based on Keene & Associates's 13F filing for Q3 2022, filed 1 Nov 2022.